The oncogenic roles of p53 mutants in mouse models

被引:60
|
作者
Lozano, Guillermina [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA
关键词
D O I
10.1016/j.gde.2006.12.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumors associated with p53 usually contain missense mutations in the p53 tumor suppressor gene rather than deletions of p53, suggesting a growth advantage for cells with missense mutations. The oncogenic roles of p53 mutants have been examined extensively in cell lines. Mouse models that inherit p53 mutations expressed at physiological levels have now been generated to examine the activities of mutant p53 upon tumorigenesis in vivo. Mice with p53 mutations develop tumor spectrums and metastatic phenotypes different from those of mice with a p53-null allele. Embryo fibroblasts with mutant p53 also show increased proliferative and transformation properties. One mechanism for this gain-of-function potential is the inhibition of function of the p53 family members p63 and p73.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 50 条
  • [31] Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
    Hrstka, Roman
    Coates, Philip J.
    Vojtesek, Borivoj
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (03) : 440 - 453
  • [32] Mouse models with modified p53 sequences to study cancer and ageing
    Clarke, AR
    Hollstein, M
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (04): : 443 - 450
  • [33] Insights into aging obtained from p53 mutant mouse models
    Dumble, M
    Gatza, C
    Tyner, S
    Venkatachalam, S
    Donehower, LA
    STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF AGING MAY BE FORESEEABLE, 2004, 1019 : 171 - 177
  • [34] The role of p53 in tumour suppression: lessons from mouse models
    Attardi, LD
    Jacks, T
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) : 48 - 63
  • [35] Illuminating p53 function in cancer with genetically engineered mouse models
    Garcia, Patty B.
    Attardi, Laura D.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 27 : 74 - 85
  • [36] Targeting Oncogenic Mutant p53 for Cancer Therapy
    Parrales, Alejandro
    Iwakuma, Tomoo
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [37] p53 family and oncogenic signaling in cancer metastasis
    Xiao, Zhi-Xiong
    Lv, Tao
    Wan, Yang
    Bergholz, Johann
    Zhang, Yujun
    CANCER RESEARCH, 2016, 76
  • [38] Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions
    Cordani, Marco
    Garufi, Alessia
    Benedetti, Rossella
    Tafani, Marco
    Aventaggiato, Michele
    D'Orazi, Gabriella
    Cirone, Mara
    BIOMOLECULES, 2024, 14 (06)
  • [39] Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
    Messina, Rosa Linda
    Sanfilippo, Mariangela
    Vella, Veronica
    Pandini, Giuseppe
    Vigneri, Paolo
    Nicolosi, Maria Luisa
    Giani, Fiorenza
    Vigneri, Riccardo
    Frasca, Francesco
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (10) : 2259 - 2270
  • [40] INACTIVE P53 MUTANTS MAY ENHANCE THE TRANSCRIPTIONAL ACTIVITY OF WILD-TYPE P53
    ZHANG, W
    SHAY, JW
    DEISSEROTH, A
    CANCER RESEARCH, 1993, 53 (20) : 4772 - 4775